Compliance Rate

Compliance Rate 0%
Compliant submissions 0
Incompliant submissions 0
Total trials 0

My Organizations' Clinical Trials

Showing 7 of 7 entries
View as:

Outcome of Intravenous Thrombolysis for Stroke Patients in the 3-4.5 Hour Time Window

Phase: N/A Priority: Normal
NCT ID: NCT01770197 Org: User:
Start: 01/31/08 End: 12/31/14 Due: 12/31/15

Sitagliptin Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT01863147 Org: User:
Start: 07/31/13 End: 07/31/15 Due: 07/31/16

Early Detection of Cognitive Dysfunction in Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01830998 Org: User:
Start: 01/31/12 End: 12/31/14 Due: 12/31/15

Alpha-lipoic Acid Reduces Left Ventricular Mass in Normotensive Type 2 Diabetic Patients With Coronary Artery Disease

Phase: N/A Priority: Normal
NCT ID: NCT01877590 Org: User:
Start: 11/30/13 End: 07/31/15 Due: 07/31/16

Changes of Endothelial Function Before and After DSA in Patients With Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01556984 Org: User:
Start: 10/31/12 End: 10/31/13 Due: 10/31/14

The Relation Between Plasma Irisin Level and Endothelial Dysfunction in Type 2 Diabetes

Phase: N/A Priority: Normal
NCT ID: NCT01877603 Org: User:
Start: 07/31/13 End: 12/31/13 Due: 12/31/14

Metformin Reduces Left Ventricular Mass in Patients With Ischemic Heart Disease

Phase: N/A Priority: Normal
NCT ID: NCT01879293 Org: User:
Start: 07/31/13 End: 08/31/15 Due: 08/31/16